Use of biologically based complementary medicines in patients with neuroendocrine tumors

References

• Le TQ, Smith L, Harnett J. A systematic review - Biologically-based complementary medicine use by people living with cancer - is a more clearly defined role for the pharmacist required? Res Social Adm Pharm. 2017;13:1037–1044.
   PubMed Web of Science ®Google Scholar
• Bjelakovic G, Nikolova D, Gluud C. Antioxidant supplements and mortality. Curr Opin Clin Nutr Metab Care. 2014;17:40–44.
   PubMed Web of Science ®Google Scholar
• Chui PL, Abdullah KL, Wong LP, et al. Prayer-for-health and complementary alternative medicine use among Malaysian breast cancer patients during chemotherapy. BMC Complement Altern Med. 2014;14:425.
   PubMed Web of Science ®Google Scholar
• World Health Organization: National policy on traditional Medicine and regulation of herbal medicines. Report of a WHO global survey; in WHO (ed): ISBN 92 4 159323 7. Geneva, 2005.
   Google Scholar
• Clarke C. The use of complementary health approaches among U.S. adults with a recent cancer diagnosis. J Altern Complementary Med. 2018;24:139–145.
   PubMed Web of Science ®Google Scholar
• Judson PL, Abdallah R, Xiong Y, et al. Complementary and alternative medicine use in individuals presenting for care at a comprehensive cancer center. Integr Cancer Ther. 2017;16:96–103.
   PubMed Web of Science ®Google Scholar
• Berretta M, Della Pepa C, Tralongo P, et al. Use of complementary and alternative medicine (CAM) in cancer patients: an Italian multicenter survey. Oncotarget. 2017;8:24401–24414.
   PubMedGoogle Scholar
• Chui PL, Abdullah KL, Wong LP, et al. Quality of life in CAM and non-CAM users among breast cancer patients during chemotherapy in Malaysia. PLoS One. 2015;10:e0139952.
   PubMedGoogle Scholar
• Mao JJ, Palmer CS, Healy KE, et al. Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv. 2011;5:8–17.
   PubMed Web of Science ®Google Scholar
• John GM, Hershman DL, Falci L, et al. Complementary and alternative medicine use among US cancer survivors. J Cancer Surviv. 2016;10:850–864.
   PubMed Web of Science ®Google Scholar
• Akpunar D, Bebis H, Yavan T. Use of complementary and alternative medicine in patients with gynecologic cancer: a systematic review. Asian Pac J Cancer Prev. 2015;16:7847–7852.
   PubMedGoogle Scholar
• Pereira P, Reis AD, Diniz RR, et al. Dietary supplements and fatigue in patients with breast cancer: a systematic review. Breast Cancer Res Treat. 2018;171:515–526.
   PubMed Web of Science ®Google Scholar
• DTU Fødevareinstituttet Afdeling for ernaering: Dietary habits in Denmark 2011-2013. 2014. Available from: https://wwwfooddtudk/english/publications/nutrition
   Google Scholar
• Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11–48.
   PubMed Web of Science ®Google Scholar
• Strohle A, Zanker K, Hahn A. Nutrition in oncology: the case of micronutrients (review). Oncol Rep. 2010;24:815–828.
   PubMed Web of Science ®Google Scholar
• Norman HA, Butrum RR, Feldman E, et al. The role of dietary supplements during cancer therapy. J Nutr. 2003;133:3794S–3799S.
   PubMed Web of Science ®Google Scholar
• Borre M, Dam GA, Knudsen AW, et al. Nutritional status and nutritional risk in patients with neuroendocrine tumors. Scand J Gastroenterol. 2018;53:1–9.
   PubMed Web of Science ®Google Scholar
• Fiebrich HB, Van Den Berg G, Kema IP, et al. Deficiencies in fat-soluble vitamins in long-term users of somatostatin analogue. Aliment Pharmacol Ther. 2010;32:1398–1404.
   PubMed Web of Science ®Google Scholar
• Lind A, Wangberg B, Ellegard L. Vitamin D and vitamin B12 deficiencies are common in patients with midgut carcinoid (SI-NET). Eur J Clin Nutr. 2016;70:990–994.
   PubMed Web of Science ®Google Scholar
• Qureshi SA, Burch N, Druce M, et al. Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study. BMJ Open. 2016;6:e010765.
   PubMed Web of Science ®Google Scholar
• Maasberg S, Knappe-Drzikova B, Vonderbeck D, et al. Malnutrition predicts clinical outcome in patients with neuroendocrine neoplasia. Neuroendocrinology. 2017;104:11–25.
   PubMed Web of Science ®Google Scholar
• Whyand T, de Lima YC, Davies P. A clinical audit of patients with neuroendocrine tumours: complementary and alternative medicine (CAM) use during chemotherapy. Br J Nurs. 2019;28:387–393.
   PubMedGoogle Scholar
• Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22:415–421.
   PubMed Web of Science ®Google Scholar
• Oken M, Creech R, Tormey D, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655.
   PubMed Web of Science ®Google Scholar
• European Food Safety Authority (EFSA). Dietary Reference Values for nutrients, Summary report, European Food Safety Authority (EFSA). 2017. Available from: https://efsaonlinelibrarywileycom/doi/epdf/102903/spefsa2017e15121
   Google Scholar
• Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol. 2008;26:665–673.
   PubMed Web of Science ®Google Scholar
• Hunter D, Marinakis C, Salisbury R, et al. Complementary therapy use in metropolitan and regional Australian radiotherapy centres; do patients report effective outcomes? Support Care Cancer. 2016;24:1803–1811.
   PubMed Web of Science ®Google Scholar
• Luo Q, Asher GN. Use of dietary supplements at a comprehensive cancer center. J Altern Complement Med. 2018;24:981–987.
   PubMed Web of Science ®Google Scholar
• Knudsen VK. Danes consumption of dietary supplements. In: Fødevareinstituttet E-aD (ed). 2014. Available from: http://www.food.dtu.dk/-/media/Institutter/Foedevareinstituttet/Publikationer/Pub-2014/Danskernes_forbrug_af_kosttilskud.ashx?la=da
   Google Scholar
• Liu R, Chang A, Reddy S, et al. Improving patient-centered care: a cross-sectional survey of prior use and interest in complementary and integrative health approaches among hospitalized oncology patients. J Altern Complement Med. 2016;22:160–165.
   PubMed Web of Science ®Google Scholar
• Abdallah R, Xiong Y, Lancaster JM, et al. Complementary and alternative medicine use in women with gynecologic malignancy presenting for care at a comprehensive cancer center. Int J Gynecol Cancer. 2015;25:1724–1730.
   PubMed Web of Science ®Google Scholar
• Brooks SL, Rowan G, Michael M. Potential issues with complementary medicines commonly used in the cancer population: a retrospective review of a tertiary cancer center's experience. Asia-Pac J Clin Oncol. 2018;14:e535–e542.
   PubMed Web of Science ®Google Scholar
• Werneke U, Earl J, Seydel C, et al. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer. 2004;90:408–413.
   PubMed Web of Science ®Google Scholar
• Asher GN, Corbett AH, Hawke RL. Common Herbal Dietary Supplement-Drug Interactions. Am Fam Physician. 2017;96:101–107.
   PubMed Web of Science ®Google Scholar